-
LRRK2 Kinase Activity and Global Proteomic Biomarkers in the Gut of Patients with Parkinson’s and/or Inflammatory Bowl Disease
… (Paneth cell function). Hypothesis: We hypothesize that PD diagnosis are associated with significant changes in the … with intestinal inflammation and could serve as an early biomarker of PD in IBD patients. Impact on … will allow to use archived intestinal samples for future research and clinical PD risk stratification, as well as …
-
Neuropathological tissue collection in LRRK2 Mutant carriers with and without PD
… studies have been vital in Parkinson’s disease (PD) research. The gold-standard diagnosis of PD is confirmed at autopsy. In addition, … members without PD, scientists will be able to assess for early pathological processes in the brain that may happen …
-
Alistair James Stewart, PhD
… focuses on moving projects from the earliest stages of research toward the clinic. Having trained in biochemistry … he is responsible for the integration of new projects into the company’s portfolio and the implementation of … where his activities were focused on lead optimization and early development at Xenova Ltd. (UK), QLT Inc. (Canada) and …
-
Bill and Willie Geist Share Chapter of New Book with MJFF
May 22, 2014
… class and lots of flair, Bill and Willie Geist invite us into their wonderfully quirky and close-knit father-son … gives a frank account of when and how he first noticed the early signs, why he kept the disease secret for most of … was “slowing down” and how he felt when Bill revealed his diagnosis to the world in a late-night Facebook post. To …
-
Development of Alpha-synuclein Seed Amplification Assay in Cerebrospinal Fluid as a Robust Biomarker of Synucleinopathies
… before the onset of Parkinson’s disease (PD) symptoms. Early diagnosis and treatment of PD would therefore benefit from a … which will bring us one-step closer to moving this assay into a clinical setting. Study Design: We will compare our …
-
Michael J. Fox Foundation and Tau Consortium Announce Partnership to Develop New Imaging Tools for Devastating Neurodegenerative Diseases
October 24, 2017
… 24, 2017) -- The Michael J. Fox Foundation for Parkinson's Research (MJFF) and the Tau Consortium today announce a … and researchers to diagnose people in prodromal or early disease stage, leading care decisions and earlier … research funders; increases the flow of participants into Parkinson's disease clinical trials with its online …